Coronavirus

Chewing to curb COVID

Penn Medicine will conduct a new clinical trial to evaluate the safety and efficacy of a chewing gum designed by School of Dental Medicine researchers to trap SARS-CoV-2 in the saliva.

Katherine Unger Baillie



In the News


NPR

Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11

Paul Offit of the Perelman School of Medicine says that uncertain benefits for children and lack of historical data on bivalent vaccines might not justify pediatric authorizations for omicron boosters.

FULL STORY →



The Guardian

Biden’s claim that COVID pandemic is over sparks debate over future

PIK Professor Ezekiel Emanuel says that President Biden’s remarks reflect the general population’s current disregard of masks and pandemic precautions.

FULL STORY →



Bloomberg

This is what life’s like in the world’s strictest COVID Zero city

Amy Gadsden of Penn Global says that China’s COVID Zero policies are a stark reminder of the party state’s ability to intervene in citizens’ lives in absolute and even cruel ways.

FULL STORY →



Bloomberg Business Week

Crash course in crisis leadership

Dean Erika H. James of the Wharton School discusses the lessons and context of her new book, “The Prepared Leader,” on an episode of the Bloomberg BusinessWeek Podcast.

FULL STORY →



Los Angeles Times

The fear of public places in the age of COVID: Is it agoraphobia or something else?

Sandy Capaldi of the Perelman School of Medicine defines agoraphobia and explains what distinguishes it from other anxiety disorders in the context of the pandemic.

FULL STORY →



Philadelphia Inquirer

COVID boosters take aim just at omicron. This Penn lab is going after coronaviruses the world hasn’t seen yet

In Drew Weissman’s lab at the Perelman School of Medicine, researchers like Mohamad-Gabriel Alameh, Benjamin Davis, and Garima Dwivedi are developing pan-coronavirus vaccines to guard against future variants.

FULL STORY →